References
- Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J. Clin.58(3), 130–160 (2008).
- Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology128(1), 192–206 (2005).
- Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet.12(2), 99–110 (2011).
- Cho WC. MicroRNAs in cancer – from research to therapy. Biochim. Biophys. Acta1805(2), 209–217 (2010).
- Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol.42(8), 1273–1281 (2010).
- Balaguer F, Link A, Lozano JJ et al. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res.70(16), 6609–6618 (2010).
- Luo X, Burwinkel B, Tao S, Brenner H. MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol. Biomarkers Prev.20(7), 1272–1286 (2011).
- Kalimutho M, Di Cecilla S, Del Vecchio Blanco G et al. Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer. Br. J. Cancer104(11), 1770–1778 (2011).
- He L, Thomson JM, Hemann MT et al. A microRNA polycistron as a potential human oncogene. Nature435(7043), 828–833 (2005).
- Toyota M, Suzuki H, Sasaki Y et al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res.68(11), 4123–4132 (2008).
- Lujambio A, Calin GA, Villanueva A et al. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl Acad. Sci. USA105(36), 13556–13561 (2008).
- Schetter AJ, Leung SY, Sohn JJ et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA299(4), 425–436 (2008).
- Glöckner SC, Dhir M, Yi JM et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res.69(11), 4691–4699 (2009).
- Chang E, Park DI, Kim YJ et al. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients. Hepatogastroenterology57(10), 720–727 (2010).
- Kamimae S, Yamamoto E, Yamano HO et al. Epigenetic alteration of DNA in mucosal wash fluid predicts invasiveness of colorectal tumors. Cancer Prev. Res.4(5), 674–683 (2011).
- Suzuki H, Yamamoto E, Nojima M et al. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis31(12), 2066–2073 (2010).
- Kubo T, Toyooka S, Tsukuda K et al. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Clin. Cancer Res.17(15), 4965–4974 (2011).
- Wang Z, Chen Z, Gao Y et al. DNA hypermethylation of microRNA-34b/c has prognostic value for stage I non-small cell lung cancer. Cancer Biol. Ther.11(5), 490–496 (2011).
- Cho WC. Recent progress in genetic variants associated with cancer and their implications in diagnostics development. Expert Rev. Mol. Diagn.10(6), 699–703 (2010).
- Navin N, Hicks J. Future medical applications of single-cell sequencing in cancer. Genome Med.3(5), 31 (2011).
- Chen X, Zhang J, Zen K, Zhang CY. MicroRNAs as blood-based biomarkers of cancer. In: MicroRNAs in Cancer Translational Research. Cho WC (Ed.). Springer, NY, USA, 499–532 (2011).
- Cho WC. Circulating microRNAs as minimally invasive biomarkers for cancer theragnosis and prognosis. Front. Genet.2(7), 1–6 (2011).